Globe Life GL Health — Deferred acquisition costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globe Life in its filing.
Tagged under the XBRL concept us-gaap:DeferredPolicyAcquisitionCosts.
The official record: Globe Life’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globe Life's health — deferred acquisition costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globe Life's health — deferred acquisition costs?
- Globe Life (GL) reported health — deferred acquisition costs of $865.28M in Q1 2026.
- How has Globe Life's health — deferred acquisition costs changed year-over-year?
- Globe Life's health — deferred acquisition costs increased by 7.1% year-over-year, from $807.77M to $865.28M.
- What is the long-term trend for Globe Life's health — deferred acquisition costs?
- Over 3 years (2022 to 2025), Globe Life's health — deferred acquisition costs has grown at a 7.3% compound annual growth rate (CAGR), from $2.69B to $3.32B.
- What does health — deferred acquisition costs mean?
- The balance of upfront costs to acquire new customers that are spread out over time.
- How do you interpret health — deferred acquisition costs?
- High levels indicate aggressive growth in new business, while a decline may signal reduced marketing spend or lower new policy issuance.
- How does health — deferred acquisition costs compare across companies?
- Standard 'DAC' (Deferred Acquisition Costs) asset found on the balance sheets of all major insurance companies.